//
home

Latest Post

Biosimilars: Close to the Real Thing

The issue of “biosimilar” medications has been under debate for years. Now, the U.S. Food and Drug Administration (FDA) is on the cusp of approving the first biosimilar. In case you don’t know, biosimilars are less expensive versions of already approved biological medications used for cancer, autoimmune, and other diseases. Biologic medications are typically large … Continue reading

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 145 other followers

Twitter Updates

Follow

Get every new post delivered to your Inbox.

Join 145 other followers